Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 1 for:    HR-11-001
Previous Study | Return to List | Next Study

An Exploratory Study of Gemcitabine Hydrochloride Oral Formulation (D07001-F4) in Subjects With Malignant Tumors

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
InnoPharmax Inc.
ClinicalTrials.gov Identifier:
NCT01678690
First received: August 29, 2012
Last updated: August 31, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2014
  Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)